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The nose and open skin areas are considered the most important sites for colonization. The
aim of our study was to assess the prevalence and to describe the antibiotic susceptibility
pattern of CA-MRSA among outpatient children.
Patients and methods: We prospectively screened every third consecutive child presenting to
our pediatric emergency department of King Saud Medical City, a 275 bed tertiary care teach-
ing hospital in Riyadh, Saudi Arabia, from March through July 2015.
Results: We analyzed a total of 830 screening results (n Z 478 males, 57.6%). Most of the
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The prevalence of community-associated methicillin-resistant Staphylococcus aureus 137be colonized with S. aureus, and of these 38 (4.6%) with MRSA. Thus, the MRSA rate amongst all
S. aureus carriers was 23.2%. All MRSA were susceptible to vancomycin, (94.7%) were suscep-
tible to linezolid, (65.8%) to clindamycin, and (89.5%) to trimethoprim/sulfamethoxazole.
Conclusion: The rate of MRSA carriage among children in Riyadh province was within the range
reported internationally. As the MRSA rate among S. aureus infected children was 23.2%,
empirical MRSA coverage should be considered in children with suspected S. aureus infections.
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The emergence of methicillin-resistant Staphylococcus
aureus (MRSA) infections among previously healthy persons
in community settings, without exposure to health care
facilities, has been noted recently [1,2]. Community-
associated (CA)-MRSA strains and healthcare-associated
(HA)-MRSA strains differ in terms of epidemiology, micro-
biology, and clinical manifestations [3]. The rapid spread of
CA-MRSA has been characterized by outbreaks of cutaneous
infections in healthy individuals, but can also cause soft
tissue and bone infections, sepsis and endocarditis, as well
as necrotizing, frequently lethal pneumonia, especially
after influenza infection.
Colonization rates of CA-MRSA have been reported to
range from 0 to 9.2 percent [4]. The nose and open skin
areas (e.g., wounds and device exit sites) are considered
the most important sites for colonization [5,6]. Nasal car-
riage of MRSA is an important risk factor for subsequent
MRSA infection and transmission of this pathogen [7].
Several studies have shown that the prevalence of CA-
MRSA varies geographically. Global outbreaks have been
reported from the United States (US) and New Zealand [8].
In a population-based surveillance study of three US com-
munities in 2001e2002, 8%e20% of all MRSA isolates were
CA-MRSA by definition, with the highest incidence among
children <2 years old [9]. King et al also demonstrated that
approximately two-thirds of all community-associated S.
aureus skin infections in Atlanta were due to MRSA clones
300 [10].
The highest rates of CA-MRSA carriage (>50%) are re-
ported in North and South America, Asia, and Malta. In-
termediate rates (25e50%) are reported in China, Australia,
Africa, and some European countries, such as Portugal
(49%), Greece (40%), Italy (37%) and Romania (34%). Other
European countries, including the Netherlands and Scandi-
navian Countries, have generally low prevalence rates.
However, epidemiological data from separate studies are
often not comparable, owing to differences in study design
and populations sampled [11].
Although several studies have reported the prevalence
of MRSA nasal carriage in patients in health care settings
[12,13], this subject has been rarely investigated in healthy
individuals in the broader community [14]. In Saudi Arabia,
CA-MRSA was assessed by Fawzia et al in outpatient chil-
dren at a university hospital from 2005 to 2008, where they
found that 29.8% of clinical S. aureus isolates were CA-
MRSA [15]. Of these cases, 64.7% were not associatedwith known risk factors. However, they evaluated clinical
isolates rather than conducting active screening for MRSA.
Another study on the prevalence of MRSA in the Western
region of Saudi Arabia found that the prevalence of MRSA
was 39.5% [16]. Infection was commonly associated with
wound, skin, and soft tissue infections.
Currently, no data in Saudi Arabia on MRSA carriage in
children is available. We aimed to assess the prevalence
and to describe the antibiotic susceptibility pattern of
MRSA among outpatient children in King Saud Medical City,
a 1400 bed tertiary care hospital with a 275-bed children’s
hospital in Riyadh, Saudi Arabia.
2. Patients and methods
The study was approved by Research Advisory Council at
this center. Informed consent was obtained from all legal
guardians of participants.
2.1. Study design
We prospectively screened the anterior nares of children
presenting to our pediatric emergency department of King
Saud Medical City, a 275 bed tertiary care teaching hospital
in Riyadh, Saudi Arabia, from March through July 2015.
Children under the age of 14 years who presented to the
emergency department were eligible for the study. Patients
who were hospitalized during the 12 months prior to their
emergency visit, and those who were known MRSA colo-
nizers, were excluded from the study. Thus, all newly
detected MRSA colonizers in our study were defined as CA-
MRSA.
Specimens were taken from each third consecutive pa-
tient meeting the inclusion criteria, and each patient was
enrolled only once during the study period.
The attending emergency physician collected data on
patient demographics (age, gender and history of recent
hospitalization, antibiotic use and MRSA carriage).
2.2. Laboratory methods
A swab from each opening of the anterior nares were
collected using pre-moistened sterile cotton swabs with
normal saline solution, and were transported in Amie’s
transport medium.
Nasal swabs were processed within 2 h of collection and
primary plating was done on mannitol salt agar (MSA)
138 F. Alaklobi et al.without oxacillin to screen for S. aureus. After inoculation,
plates were incubated at 35 C in oxygen and read after 24
and 48 h. Each distinctive morphotype of mannitol fer-
menting colonies (yellow colonies) was selected from the
MSA plate and sub-cultured on a 5% sheep blood agar plate.
The colony was confirmed as S. aureus by catalase, slide
coagulase (Staphaurex, Remel) and DNase tests. BD
Phoenix Automated Microbiology System (Becton Dick-
inson, Franklin Lakes, New Jersey) was used for identifi-
cation and antibiotics susceptibility testing for S. aureus
species, which included testing for inducible clindamycin
resistance. Tested antibiotics included: penicillin,
oxacillin, erythromycin, clindamycin, sulfamethaxazole,
vancomycin, linezolid, rifampin, ciprofloxacin and dapto-
mycin. Any S. aureus that was resistant to oxacillin and/or
cefoxitin was defined as MRSA.
2.3. Statistical analysis
The carriages rate was reported as the percentage of pos-
itive cases with S. aureus and MRSA colonization, respec-
tively, out of the total number of patients sampled.
Antibiotic susceptibility for patients colonized with MRSA
was reported as the percentage of susceptible isolates out
of total positive cases. We compared sex and age as risk
factors for carriage using Chi-square statistics and Man-
neWhitney U-test for non-normally distributed continuous
data, respectively. A P < .05 was considered statistically
significant. Statistical analyses were conducted using the
SPSS version 18 (Chicago, IL).
3. Results
830 consented children were enrolled, (57.6%) were male.
Most of the screened patients were from Riyadh (n Z 824,
99.3%). A minority were from Asir (NZ 4, 0.5%) and Alqasim
(n Z 2, 0.2%). A total of 164 (19.8%) were found to be
colonized with S. aureus, and of those 38 (4.6%) with MRSA
(Table 1). Thus, the MRSA rate amongst all S. aureus car-
riers was 23.2%.
The carriage rates were similar among males and fe-
males with an odds ratio (OR) of 1.31 (95% confidence in-
terval (CI) 0.92e1.86; P Z .131) for S. aureus carriage and
1.14 (0.58e2.21; P Z .708) for MRSA, respectively.
The age of the patients ranged from 1 month to 13 years.
The median age was 34 months (interquartile range (IQR)
12e68.25 months). The median age of S. aureus carriers
was significantly higher (41.5 months, IQR 14.25e84.0) than
in non-carriers (31 months, IQR 12.0e63.25) using the
ManneWhitney U-test (PZ .045). The distribution suggests
a higher rate in the very young that drops to a lower levelTable 1 S. aureus and MRSA carriage by sex.
Overall Males Females
n (%) n (%) n (%)
Total 830 (100) 478 (100) 352 (100)
S. aureus carriage 164 (19.8) 103 (21.5) 61 (17.3)
MRSA carriage 38 (4.6) 23 (4.8) 15 (4.3)and then increases in older children (Fig. 1). Although the
median age in MRSA carriers was higher than in non-carriers
(60.0 versus 33.5 months), this difference was not statisti-
cally significant (P Z .246).
Of the 38 cases colonized with MRSA, all isolates (100%)
were vancomycin susceptible. Susceptibility rates for other
antibiotics were 94.7% for linezolid, 65.8% for clindamycin
and 89.5% for trimethoprim/sulfamethoxazole, 55.3% for
Erythromycin, 84.2% for Ciprofloxacin, 97.3% for Rifampin
and 94.7% for Daptomycin (Table 2). Seven (18.4%) isolates
were clindamycin inducible resistant.
4. Discussion
Since CA-MRSA was first reported in 1993, it continues to
emerge, and nowadays, in many areas, it is more common
than HA-MRSA strains [17]. We are not aware of any data on
the prevalence of MRSA colonization among children in
Saudi Arabia published to date. We found that 19.8% of
children without previous hospital admission or known
MRSA carriage who presented to our tertiary care emer-
gency department were S. aureus carriers, and that 4.6%
were colonized with MRSA, which is within the international
reported range [4]. Given that we excluded children with a
previous hospital admission and previously known MRSA
carriers, this rate reflects the CA-MRSA rate in children
presenting to our institution.
The MRSA rate among all S. aureus carriers was found to
be 23.2%, consistent with the reported rate from infected
children elsewhere [15]. Furthermore, we found no differ-
ence in S. aureus or MRSA prevalence rates between males
and females. However, S. aureus carriers were older than
non-carriers.
Given the higher percentage of MRSA among S. aureus
carriers, MRSA coverage should be considered for all sus-
pected moderate to severe Staphylococcal infections. All
MRSA isolates were susceptible to vancomycin, and most of
the isolates were susceptible to rifampin, linezolid,
trimethoprim/sulfamethoxazole, daptomycin and cipro-
floxacin. However, we found relatively low susceptibility
rates to clindamycin and erythromycin (65.8% and 55.3%Figure 1 S. aureus carriage by age group.
Table 2 Antibiotic susceptibility for MRSA.
Antibiotic No. of
sensitive
isolates
Percentage
Vancomycin 38 100%
Linezolid 36 94.7%
Clindamycin 25 65.8%
Trimethoprimesulfamethoxazole 34 89.5%
Erythromycin 21 55.3%
Ciprofloxacin 32 84.2%
Rifampin 37 97.4%
Daptomycin 36 94.7%
The prevalence of community-associated methicillin-resistant Staphylococcus aureus 139respectively) that would no longer justify the use of these
antibiotics for empiric MRSA coverage. Vancomycin is the
recommended empirical choice. However failure rate of
vancomycin in CA-MRSA endocarditis is high even in com-
bination therapy with gentamicin, and/or rifampin,
particularly if vancomycin MIC is 2 mg/ml or more [18e20].
Daptomycin or linezolid as well as trimpethoprim/sulfa-
methoxazole could be used as an alternative treatment
[21].
Other empirical choices include Lonezolid for CA-MRSA
pneumonia and other moderate to severe infections apart
from endocarditis or endovasculitis, and Trimetho-
primesulfamethoxazole for milder infections. These rec-
ommendations should be revised periodically based on
annual antibiogram data.
To the best of our knowledge, this is the first study
assessing the MRSA carriage rate in children in a Saudi
Arabia setting. We collected data prospectively in a sig-
nificant number of patients. However, this study also has a
number of limitations. Firstly, it was a single center study
and the rates may be different in other regions of Saudi
Arabia. Furthermore, we conducted the study in a tertiary
care emergency department setting, and the rates may be
different in other settings, e.g. in patients seen by family
physician.
Larger epidemiological studies would be needed to get a
broader understanding of the prevalence and risk factors
for MRSA, and in particular CA-MRSA carriage in the
different provinces of Saudi Arabia.
5. Conclusion
The rate of CA-MRSA carriage among children in Riyadh
province was within the range reported internationally. As
the MRSA rate among children colonized with S. aureus was
23.2%, empiric MRSA coverage should be considered in pa-
tients with suspected moderate to severe S. aureus
infections.Conflict of interest
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